Influence of GSTM1 and HLA-DRB1 on Anticitrullinated Protein Antibody in Rheumatoid Arthritis
Author Information
Author(s): Mikuls Ted R, Gould Karen A, Bynoté Kimberly K, Yu Fang, LeVan Tricia D, Thiele Geoffrey M, Michaud Kaleb D, O'Dell James R, Reimold Andreas M, Hooker Roderick, Caplan Liron, Johnson Dannette S, Kerr Gail, Richards J Steuart, Cannon Grant W, Criswell Lindsey A, Noble Janelle A, Bridges S Louis Jr, Hughes Laura, Gregersen Peter K
Primary Institution: University of Nebraska Medical Center
Hypothesis
The study aims to examine the associations of GSTM1-null with ACPA positivity in rheumatoid arthritis and assess the interaction between GSTM1 and HLA-DRB1 shared epitope.
Conclusion
The GSTM1-null genotype significantly interacts with HLA-DRB1 SE, increasing the risk of ACPA positivity in rheumatoid arthritis.
Supporting Evidence
- 76% of patients in the VARA registry were ACPA positive.
- GSTM1-null was significantly associated with ACPA positivity in the VARA registry.
- There were significant additive interactions between GSTM1 and HLA-DRB1 SE in ACPA positivity.
Takeaway
This study found that a common genetic variant can increase the chances of having a specific antibody in people with rheumatoid arthritis, especially when combined with another genetic factor.
Methodology
The study analyzed two cohorts of rheumatoid arthritis patients, examining the association of GSTM1-null genotype with ACPA positivity using logistic regression.
Limitations
The study was limited to two-way interactions and lacked sufficient power to examine more complex interactions.
Participant Demographics
The VARA cohort was predominantly male (93%) with a mean age of 64 years, while the SONORA cohort was predominantly female (72%) with a mean age of 53 years.
Statistical Information
P-Value
0.039
Confidence Interval
1.02 to 2.05
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website